Breast neoplasms Trials in Pune, India
Conditions / Breast neoplasms / Pune, India
Research into Breast neoplasms spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03556358 | Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer | COMPLETED | PHASE3 |
| NCT00445458 | A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT05514054 | A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00076024 | AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT01125566 | LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | COMPLETED | PHASE3 |
| NCT04975308 | A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00300781 | Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer | COMPLETED | PHASE2 |
| NCT04109391 | Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03 | COMPLETED | PHASE3 |
| NCT00448305 | EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients | COMPLETED | PHASE2 |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer | TERMINATED | PHASE2 |